-
Analyst: Don't Expect Anika's Latest FDA Cleared Treatment To Impact 2018
Thursday, December 28, 2017 - 12:38pm | 340Anika Therapeutics Inc (NASDAQ: ANIK) announced Wednesday it has received clearance from the U.S. Food and Drug Administration for its HA-based bone void filler, which is used to fill bone voids or defects of the skeletal system. The Analyst Barrington Research's Michael Petusky maintains an...